Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders
Shannon R. Hinson, Vanda A. Lennon, Sean J. Pittock
Handbook of clinical neurology (2016), pp. 377-403
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
Elizabeth Cotzomi, Panos Stathopoulos, Casey S. Lee, et al.
Brain (2019) Vol. 142, Iss. 6, pp. 1598-1615
Open Access | Times Cited: 81
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G
Christian Félix, Marc H. Levin, A. S. Verkman
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
Paolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3879-3896
Closed Access | Times Cited: 6
Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
Zhen Wang, Yaping Yan
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 51
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment
Sidney M. Gospe, John J. Chen, M. Tariq Bhatti
Eye (2020) Vol. 35, Iss. 3, pp. 753-768
Open Access | Times Cited: 46
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders
Chrysoula Zografou, Aigli G. Vakrakou, Panos Stathopoulos
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Neuromyelitis Optica Spectrum Disorders
Fiona Costello
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 4, pp. 1131-1170
Closed Access | Times Cited: 24
Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice
Leung-Wah Yick, Oscar Ka-Fai, Roy Chun-Laam Ng, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 45
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Staley A. Brod
Multiple Sclerosis and Related Disorders (2020) Vol. 46, pp. 102538-102538
Open Access | Times Cited: 37
The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Michael Hiltensperger, Thomas Korn
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 1, pp. a029637-a029637
Open Access | Times Cited: 35
Emerging therapeutic targets for neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Nithi Asavapanumas, A. S. Verkman
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 3, pp. 219-229
Open Access | Times Cited: 31
Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials
Tao Xue, Yanbo Yang, Qiran Lu, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 43, pp. 102166-102166
Closed Access | Times Cited: 29
The neuro-ophthalmological manifestations of NMOSD and MOGAD—a comprehensive review
Negar Moheb, John J. Chen
Eye (2023) Vol. 37, Iss. 12, pp. 2391-2398
Closed Access | Times Cited: 9
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Xiaoming Yao, A. S. Verkman
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 29
ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System
Angela Vincent
Neuroscience (2020) Vol. 439, pp. 48-61
Closed Access | Times Cited: 25
T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders
Leung-Wah Yick, Oscar Ka-Fai, Ethel Yin-Ying Chan, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 8
Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes
Zhen Wang, Wen Guo, Yuanchu Liu, et al.
Brain Behavior and Immunity (2017) Vol. 65, pp. 173-182
Closed Access | Times Cited: 27
Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders
Leung-Wah Yick, Chi-Ho Tang, Oscar Ka-Fai, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 23
High-throughput investigation of molecular and cellular biomarkers in NMOSD
Soumya S. Yandamuri, Ruoyi Jiang, Aditi Sharma, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 7, Iss. 5
Open Access | Times Cited: 22
Improving laboratory diagnostics in myasthenia gravis
Matteo Gastaldi, Silvia Scaranzin, Pietro Businaro, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 6, pp. 579-590
Closed Access | Times Cited: 18
Multiple Sclerosis and related disorders
R. John Kimoff, Marta Kamińska, Daria A. Trojan
Handbook of clinical neurology (2022), pp. 177-200
Closed Access | Times Cited: 13
Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
Yupeng Wang, Jiangping Bian, Mengyuan Yao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Autoimmune aquaporin-4 induced damage beyond the central nervous system
Dian He, Anni Zhang, Ya Li, et al.
Multiple Sclerosis and Related Disorders (2017) Vol. 18, pp. 41-46
Closed Access | Times Cited: 22
Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data
Tatjana Pekmezović, Vanja Jovičević, Marko Andabaka, et al.
Journal of Neurology (2024)
Closed Access | Times Cited: 2
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder
Giannina Arru, Elia Sechi, Sara Mariotto, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2017) Vol. 3, Iss. 4
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top